Sign in
Explore the registryTrack Cael-101's trials

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

CAEL-101OngoingActive not recruitingPhase 3Open NCT04512235 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT04512235 · Trial Tracker · ComplyRx